# Aura Biosciences (AURA) — Earnings

AURA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/aura/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.47 |
| EPS estimate | −$0.48 |
| EPS surprise | +1.67% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Aug 13, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1501796/000119312525179426/aura-20250630.htm) |

The newest results in the table are for Q2 2025, which Aura Biosciences reported on August 13, 2025. The company posted a loss of $0.47 per share, slightly narrower than the $0.48 loss expected, a 1.67% beat. The table gives no revenue figures or estimates for Aura. Compared with Q2 2024, the loss widened from $0.41 per share.

All 16 quarters in the table, from Q3 2021 to Q2 2025, were losses, mostly between $0.40 and $0.56 per share. The narrowest was $0.39 in Q3 2021 and the widest $0.56 in Q4 2021. Annual losses were $1.96 per share in 2022, $1.93 in 2023 and $1.75 in 2024. The first half of 2025 added up to a loss of $1.02 per share, wider than the $0.81 loss in the first half of 2024. Results compared with estimates were mixed: Aura beat the EPS estimate in 9 of the 16 quarters and missed in 7.

Aura reported its third-quarter results between November 9 and November 24 in 2021 through 2024, but the table has no Q3 2025 row or later quarters. The next row to appear will be Q3 2025.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 13, 2025 | −$0.48 | −$0.47 | 1.67% | — | — |
| Q1 2025 | May 15, 2025 | −$0.49 | −$0.55 | -12.02% | — | — |
| Q4 2024 | Mar 24, 2025 | −$0.44 | −$0.52 | -17.20% | — | — |
| Q3 2024 | Nov 12, 2024 | −$0.44 | −$0.42 | 4.78% | — | — |
| Q2 2024 | Aug 8, 2024 | −$0.45 | −$0.41 | 8.91% | — | — |
| Q1 2024 | May 9, 2024 | −$0.49 | −$0.40 | 17.70% | — | — |
| Q4 2023 | Mar 27, 2024 | −$0.42 | −$0.51 | -21.11% | — | — |
| Q3 2023 | Nov 9, 2023 | −$0.52 | −$0.48 | 7.83% | — | — |
| Q2 2023 | Aug 9, 2023 | −$0.49 | −$0.48 | 2.04% | — | — |
| Q1 2023 | May 11, 2023 | −$0.54 | −$0.46 | 14.81% | — | — |
| Q4 2022 | Mar 15, 2023 | −$0.51 | −$0.52 | -2.77% | — | — |
| Q3 2022 | Nov 10, 2022 | −$0.53 | −$0.54 | -1.89% | — | — |
| Q2 2022 | Aug 11, 2022 | −$0.46 | −$0.46 | -0.13% | — | — |
| Q1 2022 | May 12, 2022 | −$0.58 | −$0.44 | 23.70% | — | — |
| Q4 2021 | Mar 23, 2022 | −$0.39 | −$0.56 | -42.38% | — | — |
| Q3 2021 | Nov 24, 2021 | −$0.76 | −$0.39 | 48.91% | — | — |

## Frequently Asked Questions

### When did Aura Biosciences (AURA) last report earnings?

Aura Biosciences last reported on Aug 13, 2025, covering fiscal Q2 2025.

### Did AURA beat earnings estimates?

Yes. Aura Biosciences reported EPS of −$0.47 for Q2 2025 against a −$0.48 estimate — a 1.67% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).